• Prestigious FDA award allocated to group that developed the V&V 40 standard

    The VPH Institute is proud to announce that some industry members of the Avicenna Alliance have recently received the FDA Crosscutting Group Honor Award.
    -Read more-
  • Publication of call for tender 'Antisuperbugs'

    A call for tender “Antisuperbugs” has been published by six European procuring entities under the lead of our supporting member - Agència de Qualitat i Avaluació Sanitària de Catalunya (AQuAS).
    -Read more-
  • In Silico Trials: a systematic approach to the assessment of model credibility

    At the last ESB conference in Vienna, our president Marco Viceconti gave an inspiring perspective talk on the recent developments in in silico medicine.
    -Read more-
  • Virtual bodies for real drugs: in silico clinical trials are the future

    This article published by the Medical Futurist offers a nice overview of the potential of in silico medicine in transforming the healthcare system, from drug development to the implementation of more efficient medical treatments.
    -Read more-
  • Online consultation to shape Horizon Europe's priorities

    The European Commission has opened a public consultation on the Horizon Europe 2021-2024. It is calling on all stakeholders to contribute to co-designing and shaping the future research and innovation investment by responding to this questionnaire.
    -Read more-
  • European Commission launches tender for studies on AI and E-Health

    On 7 August 2019 the European Commission launched a tender for two studies to survey and analyse progress on the digital transformation of the health and care in the EU.
    -Read more-


More news


More events

Subscribe to the VPH Institute Newsletter


Read all the newsletters of the VPH Institute